STOCK TITAN

Relay Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Relay Therapeutics (Nasdaq: RLAY) will present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022, at 9:45 a.m. ET. Interested parties can access the live webcast through the company's website, with an archived replay available for 30 days post-presentation. Relay Therapeutics specializes in precision medicine, utilizing its innovative Dynamo™ platform to advance drug discovery aimed at targeted oncology and genetic diseases.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 9:45 a.m. ET. The presentation will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News and Presentations section through the following link: https://ir.relaytx.com/news-events/events-presentations. An archived replay of the webcast will be available for up to 30 days following the presentation.

About Relay Therapeutics

Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage precision medicines company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. Relay Therapeutics is the first of a new breed of biotech created at the intersection of disparate technologies. Relay Therapeutics’ Dynamo™ platform integrates an array of leading-edge computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. Relay Therapeutics’ initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. For more information, please visit www.relaytx.com or follow us on Twitter.

Contact:
Pete Rahmer
Chief Corporate Development Officer
617-322-0715
prahmer@relaytx.com

Media:
Dan Budwick
1AB
973-271-6085
dan@1abmedia.com


FAQ

When is Relay Therapeutics scheduled to present at the J.P. Morgan Healthcare Conference?

Relay Therapeutics will present at the J.P. Morgan Healthcare Conference on January 11, 2022, at 9:45 a.m. ET.

How can I access the Relay Therapeutics presentation?

The presentation can be accessed live on Relay Therapeutics' website under the Events section, and an archived replay will be available for 30 days afterward.

What is the focus of Relay Therapeutics' drug discovery efforts?

Relay Therapeutics focuses on precision medicine, particularly enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications.

What technology platform does Relay Therapeutics use?

Relay Therapeutics uses the Dynamo™ platform, which integrates advanced computational and experimental technologies for drug discovery.

What stock symbol is associated with Relay Therapeutics?

Relay Therapeutics is listed under the stock symbol RLAY on Nasdaq.

Relay Therapeutics, Inc.

NASDAQ:RLAY

RLAY Rankings

RLAY Latest News

RLAY Stock Data

862.02M
167.38M
1.71%
79.48%
7.3%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
CAMBRIDGE